Anomalous Venous Blood Flow and Iron Deposition in Multiple Sclerosis
暂无分享,去创建一个
[1] J. Norgauer,et al. Inflammation in stasis dermatitis upregulates MMP-1, MMP-2 and MMP-13 expression. , 2001, Journal of dermatological science.
[2] G. Perry,et al. Metal ions and oxidative protein modification in neurological disease. , 2005, Annali dell'Istituto superiore di sanita.
[3] B. Todorich,et al. Oligodendrocytes and myelination: The role of iron , 2009, Glia.
[4] M. Kaps,et al. Comparison of transcranial color-coded duplex sonography and cranial CT measurements for determining third ventricle midline shift in space-occupying stroke. , 1999, AJNR. American journal of neuroradiology.
[5] L. Rashed,et al. The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study , 2008, Multiple sclerosis.
[6] G. Johnson,et al. Microvascular Abnormality in Relapsing-remitting Multiple Sclerosis: Perfusion Mr Imaging Findings in Normal-appearing White Matter , 2003 .
[7] M. Filippi,et al. Inflammation in multiple sclerosis: the good, the bad, and the complex , 2002, The Lancet Neurology.
[8] E. Haacke,et al. Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 1 , 2008, American Journal of Neuroradiology.
[9] Ya Ke,et al. Iron misregulation in the brain: a primary cause of neurodegenerative disorders , 2003, The Lancet Neurology.
[10] E. Hatzimichael,et al. Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients , 2005, Multiple sclerosis.
[11] J. Connor,et al. Iron in the brain. , 2009, Nutrition reviews.
[12] S. De Angelis,et al. Iron regulates T-lymphocyte sensitivity to the IFN- /STAT1 signaling pathway in vitro and in vivo , 2004 .
[13] Alireza Minagar,et al. Multiple sclerosis as a vascular disease , 2006, Neurological research.
[14] K. Scharffetter-Kochanek,et al. Selective pick-up of increased iron by deferoxamine-coupled cellulose abrogates the iron-driven induction of matrix-degrading metalloproteinase 1 and lipid peroxidation in human dermal fibroblasts in vitro: a new dressing concept. , 2001, The Journal of investigative dermatology.
[15] J. Brown. The role of the fibrin cuff in the development of venous leg ulcers. , 2005, Journal of wound care.
[16] J. Sullivan. Is stored iron safe? , 2004, The Journal of laboratory and clinical medicine.
[17] B. Schaller,et al. Physiology of cerebral venous blood flow: from experimental data in animals to normal function in humans , 2004, Brain Research Reviews.
[18] P. Zamboni. The Big Idea: Iron-Dependent Inflammation in Venous Disease and Proposed Parallels in Multiple Sclerosis , 2006 .
[19] G. Gardiner. Obstructive lesions of the inferior vena cava: Clinical features and endovenous treatment , 2008 .
[20] S. Zuehlsdorff,et al. 4D Radial Acquisition Contrast-Enhanced MR Angiography and Intracranial Arteriovenous Malformations: Quickly Approaching Digital Subtraction Angiography , 2009, Stroke.
[21] M. Cambron,et al. Vascular aspects of multiple sclerosis , 2011, The Lancet Neurology.
[22] P. Zamboni. The Big Idea: Iron-Dependent Inflammation in Venous Disease and Proposed Parallels in Multiple Sclerosis , 2006, Journal of the Royal Society of Medicine.
[23] R. Floyd,et al. Regional lipid peroxidation in rat brain in vitro: Possible role of endogenous iron , 1985, Neurochemical Research.
[24] K. Ikematsu,et al. Age-associated increases in heme oxygenase-1 and ferritin immunoreactivity in the autopsied brain. , 2003, Legal medicine.
[25] J. Connor,et al. Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.
[26] G. Stoll,et al. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging , 2009, Neuroscience.
[27] B E Kendall,et al. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. , 1990, Brain : a journal of neurology.
[28] Rohit Bakshi,et al. Role of MRI in multiple sclerosis II: brain and spinal cord atrophy. , 2004, Frontiers in bioscience : a journal and virtual library.
[29] K. Burnand,et al. THE CAUSE OF VENOUS ULCERATION , 1982, The Lancet.
[30] S. LeVine,et al. The Role of Iron in the Pathogenesis of Experimental Allergic Encephalomyelitis and Multiple Sclerosis , 2004, Annals of the New York Academy of Sciences.
[31] M. Muckenthaler,et al. Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. , 2009, Journal of Alzheimer's disease : JAD.
[32] G. Porto,et al. Iron overload and immunity. , 2007, World journal of gastroenterology.
[33] S. Naylor,et al. Human transferrin: cDNA characterization and chromosomal localization. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[34] F. Salvi,et al. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[35] D. Ethell,et al. Matrix metalloproteinase-7 facilitates immune access to the CNS in experimental autoimmune encephalomyelitis , 2009, BMC Neuroscience.
[36] Z. Wu,et al. Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 2 , 2008, American Journal of Neuroradiology.
[37] Horst Urbach,et al. 4D time‐resolved MR angiography with keyhole (4D‐TRAK): More than 60 times accelerated MRA using a combination of CENTRA, keyhole, and SENSE at 3.0T , 2008, Journal of magnetic resonance imaging : JMRI.
[38] M. Atkinson,et al. An Integral Role for Heme Oxygenase-1 and Carbon Monoxide in Maintaining Peripheral Tolerance by CD4+CD25+ Regulatory T Cells 1 , 2005, The Journal of Immunology.
[39] C. Levenson,et al. Iron and ageing: an introduction to iron regulatory mechanisms , 2004, Ageing Research Reviews.
[40] R. Poston,et al. Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis , 1989, Journal of the Neurological Sciences.
[41] Ernest Beutler,et al. Brain Iron Metabolism and Neurodegenerative Disorders , 2002, Developmental Neuroscience.
[42] N. Abdelrahman,et al. Comparison of Three Different Methods for Measurement of Cervical Cord Atrophy in Multiple Sclerosis , 2008, American Journal of Neuroradiology.
[43] C. Bunker,et al. Leukocytes: their role in the etiopathogenesis of skin damage in venous disease. , 1993, Journal of vascular surgery.
[44] J R Reichenbach,et al. In vivo measurement of blood oxygen saturation using magnetic resonance imaging: A direct validation of the blood oxygen level‐dependent concept in functional brain imaging , 1997, Human brain mapping.
[45] E. Frohman,et al. Multiple sclerosis--the plaque and its pathogenesis. , 2006, The New England journal of medicine.
[46] M. Barnett,et al. The pathology of multiple sclerosis: a paradigm shift , 2006, Current opinion in neurology.
[47] F. Carinci,et al. Venous collateral circulation of the extracranial cerebrospinal outflow routes. , 2009, Current neurovascular research.
[48] S. Tognazzo,et al. The overlapping of local iron overload and HFE mutation in venous leg ulcer pathogenesis. , 2006, Free radical biology & medicine.
[49] Rohit Bakshi,et al. Iron in chronic brain disorders: Imaging and neurotherapeutic implications , 2007, Neurotherapeutics.
[50] C. W. Tjoa,et al. MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis , 2005, Journal of the Neurological Sciences.
[51] E. Haacke,et al. Imaging iron stores in the brain using magnetic resonance imaging. , 2005, Magnetic resonance imaging.
[52] S. Tognazzo,et al. Serum Iron and Matrix Metalloproteinase‐9 Variations in Limbs Affected by Chronic Venous Disease and Venous Leg Ulcers , 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[53] J. Olynyk,et al. The Regulation of Cellular Iron Metabolism , 2007, Critical reviews in clinical laboratory sciences.
[54] T. Rouault,et al. Iron on the brain , 2001, Nature Genetics.
[55] M. Ursino,et al. A simple mathematical model of the interaction between intracranial pressure and cerebral hemodynamics. , 1997, Journal of applied physiology.
[56] K. Einhäupl,et al. Assessment of normal flow velocity in basal cerebral veins. A transcranial doppler ultrasound study. , 1996, Stroke.
[57] A. Pandit,et al. The use of therapeutic gene eNOS delivered via a fibrin scaffold enhances wound healing in a compromised wound model. , 2008, Biomaterials.
[58] S. Nelson,et al. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron , 2008, Annals of neurology.
[59] J. Beard,et al. Iron-deficient mice fail to develop autoimmune encephalomyelitis. , 2003, The Journal of nutrition.
[60] Peter K Stys,et al. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis , 2009, The Lancet Neurology.
[61] Paolo Zamboni,et al. Intracranial venous haemodynamics in multiple sclerosis. , 2007, Current neurovascular research.
[62] R. Erasmus,et al. Biochemical Model for Inflammation of the Brain: The Effect of Iron and Transferrin on Monocytes and Lipid Peroxidation , 2004, Metabolic Brain Disease.
[63] C. Exley,et al. Elevated urinary excretion of aluminium and iron in multiple sclerosis , 2006, Multiple sclerosis.
[64] P. Zamboni,et al. Inflammation in venous disease. , 2008, International angiology : a journal of the International Union of Angiology.
[65] J. Raffetto. Dermal pathology, cellular biology, and inflammation in chronic venous disease. , 2009, Thrombosis research.
[66] C. Franceschi. The unsolved puzzle of multiple sclerosis and venous function , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.
[67] Young Wook Kim,et al. Primary Budd-Chiari syndrome: outcome of endovascular management for suprahepatic venous obstruction. , 2006, Journal of vascular surgery.
[68] E. Spuentrup,et al. High spatial resolution magnetic resonance imaging of experimental cerebral venous thrombosis with a blood pool contrast agent. , 2010, European journal of radiology.
[69] A. Bush,et al. Metals and neuroscience. , 2000, Current opinion in chemical biology.
[70] T. Gadelha,et al. Normal plasma antithrombin activity in patients with relapsing–remitting and secondary progressive multiple sclerosis , 2009, Clinical Neurology and Neurosurgery.
[71] A. Compston,et al. Multiple sclerosis. , 2002, Lancet.
[72] A. Lutterotti,et al. Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis , 2005, Journal of Neuroimmunology.
[73] F. Kirchhoff,et al. Glia: the fulcrum of brain diseases , 2007, Cell Death and Differentiation.
[74] M. Filippi,et al. T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis , 2009, Multiple sclerosis.
[75] E. Granieri,et al. Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis , 2006, Multiple sclerosis.
[76] B. Drayer,et al. Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? , 1987, AJR. American journal of roentgenology.
[77] P. Zamboni,et al. Urine hemosiderin: a novel marker to assess the severity of chronic venous disease. , 2003, Journal of vascular surgery.
[78] Paolo Zamboni,et al. The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis , 2009, Journal of the Neurological Sciences.
[79] I. Allen,et al. THE PATHOLOGY OF MULTIPLE SCLEROSIS‐FACT, FICTION AND HYPOTHESIS , 1981, Neuropathology and applied neurobiology.
[80] C. W. Adams,et al. Perivascular iron deposition and other vascular damage in multiple sclerosis. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[81] R. Grossman,et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging , 2009, Journal of magnetic resonance imaging : JMRI.
[82] Manu O. Platt,et al. Bone Morphogenic Protein 4 Produced in Endothelial Cells by Oscillatory Shear Stress Induces Monocyte Adhesion by Stimulating Reactive Oxygen Species Production From a Nox1-Based NADPH Oxidase , 2004, Circulation research.
[83] O. Bagasra,et al. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[84] W. L. Benedict,et al. Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.
[85] Paolo Zamboni,et al. Doppler haemodynamics of cerebral venous return. , 2008, Current neurovascular research.
[86] F. Barkhof,et al. Cortical lesions in multiple sclerosis. , 1999, Brain : a journal of neurology.
[87] J. Stankiewicz,et al. Role of iron in neurotoxicity: a cause for concern in the elderly? , 2009, Current opinion in clinical nutrition and metabolic care.
[88] F Barkhof,et al. MR venography of multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.
[89] Z. Rybak,et al. Hypothetical molecular mechanisms by which local iron overload facilitates the development of venous leg ulcers and multiple sclerosis lesions. , 2008, Medical hypotheses.
[90] G. Schmid-Schönbein,et al. Chronic venous disease. , 2006, Minerva cardioangiologica.
[91] T. Fog. The topography of plaques in multiple sclerosis with special reference to cerebral plaques. , 1965, Acta neurologica Scandinavica. Supplementum.
[92] T. J. Putnam. LESIONS OF ENCEPHALOMYELITIS AND MULTIPLE SCLEROSIS: VENOUS THROMBOSIS AS THE PRIMARY ALTERATION , 1937 .
[93] D. Chari,et al. Remyelination In Multiple Sclerosis , 2007, International Review of Neurobiology.
[94] P. Ponka,et al. Dysregulation of Iron Homeostasis in the CNS Contributes to Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis , 2009, The Journal of Neuroscience.
[95] F. Barkhof,et al. Use of ultrasmall superparamagnetic particles of iron oxide (USPIO)‐enhanced MRI to demonstrate diffuse inflammation in the normal‐appearing white matter (NAWM) of multiple sclerosis (MS) patients: An exploratory study , 2009, Journal of magnetic resonance imaging : JMRI.
[96] J. Caillé,et al. MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium. , 2006, AJNR. American journal of neuroradiology.
[97] A. Koeppen,et al. The history of iron in the brain , 1995, Journal of the Neurological Sciences.
[98] Frederik Barkhof,et al. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. , 2008, Brain : a journal of neurology.